In colorectal cancers, the downregulation of retinoic acid receptors (RARs) (1.02 f mol/μg DNA in cancer cells with respect to 2.64 f mol/μg DNA in normal cells) [1] and the downregulation or loss of retinoid X receptor (RXR)-α have been largely demonstrated [2]. Here, RARS1 is linked to cancer.